Towards the safer clinical translation of human induced pluripotent stem cell–derived cells to regenerative medicine-Reference-Cited by-同舟云学术

Towards the safer clinical translation of human induced pluripotent stem cell–derived cells to regenerative medicine

Published:2015 Issue: Volume:2 Page:15032
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Tani Kenzaburo

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference3 articles.

1. RIKEN et al. canceled the iPS transplantation for the second case due to gene mutations;Gouda,2015

2. The safety of human pluripotent stem cells in clinical treatment;Simonson;Annal Med,2015

3. Conditionally replicating adenovirus prevents pluripotent stem cell-derived teratoma by specifically eliminating undifferentiated cells;Mitsui,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular matrix mechanics regulate transfection and SOX9-directed differentiation of mesenchymal stem cells;Acta Biomaterialia;2020-07

2. Secretome of Mesenchymal Stem Cells and Its Potential Protective Effects on Brain Pathologies;Molecular Neurobiology;2019-04-02

3. Induced pluripotent stem cells (iPSCs) as a new source of bone in reconstructive surgery: A systematic review and meta-analysis of preclinical studies;Journal of Tissue Engineering and Regenerative Medicine;2018-06-19

4. Forced differentiation in vitro leads to stress-induced activation of DNA damage response in hiPSC-derived chondrocyte-like cells;PLOS ONE;2018-06-04

5. iPSCs-based generation of vascular cells: reprogramming approaches and applications;Cellular and Molecular Life Sciences;2017-12-14